Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Roden

Showing results (131-140 of 237) with videos related to

Pageof 24
Sort By:
American Heart Journal|December 1, 1986
Effect of Fluosol-DA on infarct morphology and vulnerability to ventricular arrhythmiaF D Kolodgie, A K Dawson, D M Roden, et al.
British Journal of Clinical Pharmacology|April 1, 1989
Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effectC Funck-Brentano, H K Kroemer, H Pavlou, et al.
Biochimica Et Biophysica Acta|January 16, 1999
Human MRP3 transporter: identification of the 5'-flanking region, genomic organization and alternative splice variantsM F Fromm, B Leake, D M Roden, et al.
British Journal of Clinical Pharmacology|September 1, 1991
Phenotypic debrisoquine 4-hydroxylase activity among extensive metabolizers is unrelated to genotype as determined by the Xba-I restriction fragment length polymorphismJ Turgeon, W E Evans, M V Relling, et al.
British Journal of Clinical Pharmacology|August 1, 1990
A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonismC Funck-Brentano, D J Silberstein, D M Roden, et al.
The American Journal of Cardiology|September 1, 1984
Differential effects of O-demethyl encainide on induced and spontaneous arrhythmias in the conscious dogA K Dawson, D M Roden, H J Duff, et al.
Circulation|October 15, 1996
Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTSD M Roden, R Lazzara, M Rosen, et al.
Clinical Pharmacology and Therapeutics|September 1, 1982
Pharmacologic reversal of hypotensive effect complicating antiarrhythmic therapy with bretyliumR L Woosley, S B Reele, D M Roden, et al.
Clinical Pharmacology and Therapeutics|June 1, 1988
Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointesK A Thompson, J J Murray, I A Blair, et al.
The American Journal of Cardiology|March 1, 1988
Tocainide plus quinidine for treatment of ventricular arrhythmiasJ T Barbey, K A Thompson, D S Echt, et al.
Pageof 24

Showing results (131-140 of 237) with videos related to

Sort By:
Pageof 24
American Heart Journal|December 1, 1986
Effect of Fluosol-DA on infarct morphology and vulnerability to ventricular arrhythmiaF D Kolodgie, A K Dawson, D M Roden, et al.
British Journal of Clinical Pharmacology|April 1, 1989
Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effectC Funck-Brentano, H K Kroemer, H Pavlou, et al.
Biochimica Et Biophysica Acta|January 16, 1999
Human MRP3 transporter: identification of the 5'-flanking region, genomic organization and alternative splice variantsM F Fromm, B Leake, D M Roden, et al.
British Journal of Clinical Pharmacology|September 1, 1991
Phenotypic debrisoquine 4-hydroxylase activity among extensive metabolizers is unrelated to genotype as determined by the Xba-I restriction fragment length polymorphismJ Turgeon, W E Evans, M V Relling, et al.
British Journal of Clinical Pharmacology|August 1, 1990
A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonismC Funck-Brentano, D J Silberstein, D M Roden, et al.
The American Journal of Cardiology|September 1, 1984
Differential effects of O-demethyl encainide on induced and spontaneous arrhythmias in the conscious dogA K Dawson, D M Roden, H J Duff, et al.
Circulation|October 15, 1996
Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTSD M Roden, R Lazzara, M Rosen, et al.
Clinical Pharmacology and Therapeutics|September 1, 1982
Pharmacologic reversal of hypotensive effect complicating antiarrhythmic therapy with bretyliumR L Woosley, S B Reele, D M Roden, et al.
Clinical Pharmacology and Therapeutics|June 1, 1988
Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointesK A Thompson, J J Murray, I A Blair, et al.
The American Journal of Cardiology|March 1, 1988
Tocainide plus quinidine for treatment of ventricular arrhythmiasJ T Barbey, K A Thompson, D S Echt, et al.
Pageof 24